VIICTR Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
Return to Top
Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer.
Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer. Int J Mol Sci. 2023 Feb 15; 24(4).
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Apoptosis
Cell Cycle Proteins
Cell Line, Tumor
Cell Proliferation
Endometrial Neoplasms
Female
Humans
Mice
Molecular Targeted Therapy
Protein Kinase Inhibitors
Protein-Tyrosine Kinases
Receptor, EphA2